response to treatment in an adherence intervention trial for relapsing-remitting multiple sclerosis patients [published online November 28, 2018]. J Clin Psychol. 2018. doi: 10.1002/jclp.22725.
home / authors / response-to-treatment-in-an-adherence-intervention-trial-for-relapsing-remitting-multiple-sclerosis-patients-published-online-november-28-2018-j-clin-psychol-2018-doi-101002-jclp22725
Articles
January 26th 2019
Exploring Novel Reasons for Nonadherence to Disease-Modifying Therapies
Schoor R, Bruce A, Bruce J, et al. Reasons for nonadherence response to treatment in an adherence intervention trial for relapsing-remitting multiple sclerosis patients [published online November 28, 2018]. J Clin Psychol. 2018. doi: 10.1002/jclp.22725.
Latest Updated Articles
Published: November 15th 2024 | Updated: November 19th 2024
FDA Approves Revumenib for R/R Acute Leukemia With a KMT2A Translocation
Published: April 1st 2024 | Updated: November 5th 2024
What We're Reading: Concierge Nonprofit Hospitals; Kaiser Permanente Elderly Care Program; Health Care Not Among Top Voter Issues
Published: October 21st 2024 | Updated: October 24th 2024
Lower Diagnostic Error Rates Found Among Hospitalized Patients During Care Transitions
Published: September 26th 2024 | Updated: October 1st 2024
Addressing Natural Disaster Takes Cooperation, Preparation to Ensure Patient Health
Published: May 9th 2024 | Updated: May 21st 2024
FDA Accepts Nivolumab Subcutaneous Injection Application, With Potential to Boost Access to PD-1 Inhibitors
Published: December 19th 2024 | Updated: December 28th 2024
The Dangerous Intersection of Breast Cancer and Cardiovascular Disease: A Call for Improved Prevention
